• External face of clinical development team, implementing major protocol amendment and working closely with 15 clinical trial sites to accelerate enrollment and complete Phase 2 study on schedule• Connect external Key Opinion Leaders (KOLs) with internal clinical development team to gather input on protocol and clinical trial design to optimize protocols prior to initiating enrollment• Identify and engage with new clinical trial sites and KOLs for upcoming Phase 2 and 3 studies• Congress medical strategy planning, ensuring key disease state and competitive information is covered and spearheading KOL meetings to identify collaboration opportunities

• Pre-launch engagement and KOL identification for over 60 regional neuromuscular specialists and general neurologists• Clinical trial support for 6 ongoing Phase 2-Phase 3b adult and pediatric studies• Neuromuscular rare disease launch experience, launching Vyvgart (efgartigimod), a first in class anti-FcRn drug, during a global pandemic• Medical support for commercial sales team training and speaker training

• Onboarding trainer for newly hired MSLs, covering Kesimpta (ofatumumab) clinical development and Phase II/III trial data• Anti-CD20 mAb medical launch experience, launching a newly approved drug during a global pandemic, collaborating with internal and external stakeholders pre- and post-launch to ensure a successful launch for providers and patients• Regional team trainer organizing and leading training calls, coordinating with Field Medical Capabilities to identify training needs for the team• BTKi Competitive Strategy Lead working closely with US and Global medical teams to collect up-to-date data on BTKi molecules in development to inform internal competitive strategy• Peer-nominated to Leadership Advisory Board as trusted colleague to liaise between MSLs and leadership to identify strengths/challenges and propose solution-oriented ideas• Scientific and clinical data expert on anti-CD20 and S1P products, developing strong peer-to-peer relationships with KOLs through medical education

• Medical team lead providing Erelzi training for commercial team at sales launch, collaborating with Sales Training Manager to develop training materials• Collaborate with internal launch teams as Erelzi MSL team lead to ensure launch readiness across all teams• Advance HCP knowledge on therapeutic monoclonal antibodies and biosimilars via non-promotional, scientific presentations• Support internal sales and marketing teams to develop their scientific and technical expertise through the delivery of scientific update presentations

• Collaborate with a multidisciplinary and international team to develop 55 new ideas• Explore 3 business areas to identify novel business opportunities for Blockchain• Identify and engage key stakeholders across 15 business sectors• Rapidly research and analyze market trends for key concept areas• Develop business models for each project, including timeline, budget, and team/experience required• Successfully pitch 3 new business concepts to top management

•Analyzed and evaluated various methods of transfection to optimize conditions for genetic modification of human embryonic stem cells•Collaborated with company representatives to test new products designed for human embryonic stem cell culturing•Designed and created a targeting vector•Genetically modified human embryonic stem cells to create a fluorescent reporter to identify cells differentiating towards corticospinal motor neurons (CSMNs)•Directed differentiation of human embryonic stem cells towards the neuronal lineage•Purified neural progenitor cells via fluorescence activated cell sorting• Identified key genes involved in development and maintenance of CSMN identity• Transplanted human neural progenitor cells into neonatal mouse brains to identify if cells continue differentiating into CSMNs and integrate into the mouse brain and spinal cordSkills/techniques: Culturing hESCs, cloning, gene targeting in hESCs, neural differentiation of hESCs, Western blot, PCR, RT-PCR, immunocytochemistry, FACS

Demonstrated human embryonic stem cell methods to graduate students, postdoctoral fellows, and clinical fellows

Taught 3-day science curriculum to local middle schools.Topics covered: Identifying differences between genetically modified fruit flies under a microscope, DNA extraction, gel electrophoresis

Studying the role of galectin-3 in pre-mRNA splicing.Skills/techniques: SDS-PAGE, Western blot, Immunoprecipitation, Yeast two hybrid